URIEXO
Live / Registered — Registered (as of 14 Feb 2023)
What this means for you
Registered since 14 Feb 2023. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 14 Feb 2029: the §8 declaration of use).
Record
- Serial number
- 97040525
- Registration number
- 6977243
- Mark type
- Word mark
- Filed
- 22 Sept 2021
- Published for opposition
- 29 Nov 2022
- Registered
- 14 Feb 2023
- Next maintenance filing
- §8 declaration of use, due by 14 Feb 2029 (grace period to 14 Aug 2029)
- Attorney of record
- Ellen A. Andelman
Goods and services
- Class 005 — Pharmaceuticals: Anti-infectives; diagnostic reagents for medical diagnostic use; diagnostic reagents for medical laboratory use; herbal supplements for the treatment of infectious diseases, namely, urinary tract infections; medical diagnostic reagents; medical diagnostic reagents and assays for testing of body fluids; urinary tract disinfectants; Pharmaceutical preparations for the prevention of urinary tract infections and associated symptoms; Pharmaceutical preparations in the form of vegicapsules for oral use for the treatment of urinary tract infections; Herbal dietary supplements for the prevention of infectious diseases, namely, urinary tract infections and associated symptoms
Owner
- 12385236 Canada Inc., Saint-Laurent, Quebec, CA
- 12385236 Canada Inc., Saint-Laurent, Quebec, CA
- 12385236 Canada Inc., Saint-Laurent, Quebec, CA
Prosecution history
- 14 Feb 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 14 Feb 2023 — REGISTERED-PRINCIPAL REGISTER
- 29 Nov 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 29 Nov 2022 — PUBLISHED FOR OPPOSITION
- 09 Nov 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 28 Oct 2022 — NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
- 27 Oct 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 27 Oct 2022 — USE AMENDMENT ACCEPTED
- 24 Oct 2022 — AMENDMENT TO USE PROCESSING COMPLETE
- 12 Sept 2022 — USE AMENDMENT FILED
- 21 Oct 2022 — ASSIGNED TO LIE
- 12 Sept 2022 — TEAS AMENDMENT OF USE RECEIVED
- 27 Jun 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 27 Jun 2022 — NON-FINAL ACTION E-MAILED
- 27 Jun 2022 — NON-FINAL ACTION WRITTEN